To discover SGOL2-MAD2 associated potential pathways in HCC patients, we used the data from LinkedOmics to identify differentially expressed genes related to both SGOL2 and MAD2 in HCC by Spearman’s test (Fig. S6A, D). This evidence concerns the gene SGO2 and hepatocellular carcinoma.